HomeCompareLEMIF vs JNJ

LEMIF vs JNJ: Dividend Comparison 2026

LEMIF yields 970.50% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LEMIF wins by $14521917.58M in total portfolio value
10 years
LEMIF
LEMIF
● Live price
970.50%
Share price
$0.21
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$14521917.61M
Annual income
$12,074,477,969,636.73
Full LEMIF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — LEMIF vs JNJ

📍 LEMIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLEMIFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LEMIF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LEMIF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LEMIF
Annual income on $10K today (after 15% tax)
$82,492.24/yr
After 10yr DRIP, annual income (after tax)
$10,263,306,274,191.22/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, LEMIF beats the other by $10,263,306,270,153.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LEMIF + JNJ for your $10,000?

LEMIF: 50%JNJ: 50%
100% JNJ50/50100% LEMIF
Portfolio after 10yr
$7260958.82M
Annual income
$6,037,238,987,193.31/yr
Blended yield
83.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LEMIF
No analyst data
Altman Z
4.0
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LEMIF buys
0
JNJ buys
0
No recent congressional trades found for LEMIF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLEMIFJNJ
Forward yield970.50%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$14521917.61M$30.5K
Annual income after 10y$12,074,477,969,636.73$4,749.88
Total dividends collected$14334115.01M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LEMIF vs JNJ ($10,000, DRIP)

YearLEMIF PortfolioLEMIF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$107,750$97,049.69$10,594$274.49+$97.2KLEMIF
2$1,092,589$977,296.63$11,294$360.69+$1.08MLEMIF
3$10,430,613$9,261,542.76$12,133$476.91+$10.42MLEMIF
4$93,793,588$82,632,832.51$13,156$635.42+$93.78MLEMIF
5$794,795,080$694,435,940.81$14,432$854.61+$794.78MLEMIF
6$6,350,022,231$5,499,591,495.32$16,056$1,162.76+$6350.01MLEMIF
7$47,859,041,788$41,064,518,000.31$18,175$1,604.53+$47859.02MLEMIF
8$340,458,067,570$289,248,892,857.73$21,009$2,252.68+$340458.05MLEMIF
9$2,287,326,769,030$1,923,036,636,729.58$24,911$3,229.73+$2287326.74MLEMIF
10$14,521,917,612,499$12,074,477,969,636.73$30,458$4,749.88+$14521917.58MLEMIF

LEMIF vs JNJ: Complete Analysis 2026

LEMIFStock

Leading Edge Materials Corp. explores for and develops a portfolio of raw material projects in Europe. The company primarily explores for graphite, lithium, nickel, cobalt, and rare earth elements. It holds a 100% interest in the Woxna graphite project that includes four concessions consisting of Kringelgruven, Mattsmyra, Gropabo, and Mansberg located in Gavleborg County, central Sweden. The company also holds interests in the Norra Karr HREE project located in south-central Sweden; and a 51% interest in the Bihor Sud nickel cobalt exploration alliance located in Romania. Leading Edge Materials Corp. was formerly known as Flinders Resources Limited and changed its name to Leading Edge Materials Corp. in August 2016. The company is headquartered in Vancouver, Canada.

Full LEMIF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this LEMIF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LEMIF vs SCHDLEMIF vs JEPILEMIF vs OLEMIF vs KOLEMIF vs MAINLEMIF vs ABBVLEMIF vs MRKLEMIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.